Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

Human Papilloma-Specific IgG ELISA Kit

Human Papillomavirus (HPV) is a highly prevalent group of viruses that can infect skin and mucosal surfaces. With over 200 different types, HPV is categorized into low-risk and high-risk groups based on their potential to cause cancer. Low-risk types, such as HPV-6 and HPV-11, are primarily associated with benign conditions like anogenital warts. In contrast, high-risk types, including HPV-16, HPV-18, and others, are the primary cause of cervical, anal, oropharyngeal, and other anogenital cancers.The Human Papilloma-Specific IgG ELISA Kit is a crucial diagnostic tool that offers a sensitive and specific method for the quantitative or semi-quantitative detection of these antibodies.

Human Papillomavcirus.Figure 1. Human Papillomavirus (HPV).

Why Is It Challenging To Detect HPV IgG Antibodies?

Unlike measles or varicella virus, HPV infection has its own characteristics:

Challenging To Detect HPV IgG Antibodies

Localized infection: HPV infection is strictly limited to the epithelial cells of the skin and mucous membranes, and the virus does not enter the bloodstream.

Weak serological response: Limited exposure to viral antigens results in only about 50-70% of infected individuals producing detectable serum antibodies, and antibody levels are typically low.

Type specificity: The antibody response has high type specif  icity, meaning that antibodies against HPV 16 do not neutralize HPV 18. Therefore, detection must be targeted at specific types.

The importance of conformational epitopes: The most critical neutralizing antibody epitope is located on the conformational spatial structure formed by L1 protein assembly. Only antigens that can maintain this three-dimensional structure, such as VLPs, can effectively detect antibodies with neutralizing activity.

Technology Platform

Technology Platform

  • Bridging ELISA
  • Indirect ELISA
  • Competitive ELISA
  • Homogeneous ELISA

Sample Type Compatibility

  • Human Serum
  • Human Plasma
  • Other Biological Fluids
  • Clinical Trial Samples

Sensitivity Profile

  • High Sensitivity
  • Ultra-High Sensitivity
  • Regulatory-Compliant
  • Matrix Interference-Optimized

Kit Features

  • Pre-Coated Microplate
  • Complete Reagent Set
  • Automation-Compatible
  • Wide Dynamic Range
  • Stable Storage (2-8℃, long shelf-life)
  • Rapid Assay Protocol

Key Components & Specifications

Performance Characteristics

  • A high-quality Human Papilloma-Specific IgG ELISA kit is characterized by robust performance metrics:
  • Sensitivity: The ability to accurately detect a positive antibody response, minimizing false negatives. This is crucial for evaluating vaccine efficacy.
  • Specificity: The ability to distinguish HPV-specific antibodies from other antibodies, ensuring minimal cross-reactivity and avoiding false positives.
  • Accuracy and Precision: The kit must provide results that are both close to the true value and highly reproducible. This includes excellent intra- and inter-assay precision.
  • Assay Range: The kit should have a broad linear range to accurately quantify a wide spectrum of antibody concentrations, from low to high titers.

Interpretation of Results and Determination of Cut off

  • There is no unified "immune protection" threshold for HPV serology. The interpretation of the results usually depends on the critical values set by the experiment.
  • Critical value calculation: usually determined by detecting the OD values of a large number of known negative samples. The critical value is often defined as the average OD value of the negative population plus 3 or 5 times the standard deviation. The reagent kit instructions will provide clear formulas and recommended critical values.
  • Positive: Sample concentration>critical value. Indicating the presence of specific IgG antibodies against this type of HPV, suggesting previous infection or vaccination.
  • Negative: Sample concentration
  • Borderline/Evacual: A small range of sample concentration near the critical value. Suggest retesting or follow-up sampling.

Sample Requirements

  • Sample Types: Valid for human serum/plasma (EDTA, heparin, or citrate anticoagulated); other fluids (e.g., saliva) need additional validation.
  • Sample Collection: Serum: collect via venipuncture, clot at 20-25°C for 30-60 mins, centrifuge at 1500×g for 10 mins. Plasma: centrifuge immediately post-collection at 1500×g for 10 mins to prevent hemolysis.
  • Sample Storage: Fresh samples preferred. Store serum/plasma at 2-8°C for up to 5 days.
  • Sample Preparation: Thaw frozen samples at room temp, mix gently. Avoid/pretreat samples with severe hemolysis, lipemia, or turbidity.

Data Calculation

  • Calculate the average OD value: After correcting the blank well, calculate the average OD value of the calibration sample and sample wells.
  • Draw a standard curve: Using the calibration concentration (logarithmic coordinate) as the X-axis and the average OD value (linear coordinate) as the Y-axis, fit the curve using four parameter logic (4-PL).
  • Concentration calculation: Interpolate the concentration from the standard curve based on the sample OD value, and multiply it by the dilution factor to obtain the final concentration (AU/mL or mMU/mL)

Applications of the Measles IgG ELISA Kit

Assessment of Vaccine Efficacy for HPV

Assessment of Vaccine Efficacy

The primary application of this ELISA kit is to evaluate the serological response to HPV vaccination. The current HPV vaccines are based on VLPs of specific high-risk types (e.g., HPV-16, HPV-18) and low-risk types (e.g., HPV-6, HPV-11). Measuring antibody titers post-vaccination provides a key metric of a successful immune response.

Epidemiological and Seroprevalence Studies for HPV

Epidemiological and Seroprevalence Studies

Serological testing is an invaluable tool for conducting large-scale epidemiological studies to determine the prevalence of past HPV exposure within a population. Unlike DNA tests, which detect current infection, an antibody test can provide insight into cumulative exposure over an individual's lifetime.

Human Papilloma-Specific IgG ELISA Kits

ParameterDetails
Product nameHuman Papilloma Virus IgG ELISA kit
Sampleplasma, serum
Intended UseEnzyme Immuno Assay (EIA) for determination of IgG class antibodies to Human Papilloma Virus (or HPV) in human plasma and sera.
The product is supplied for research purpose only. It is not for use in the diagnosis or for the follow-up of patients administered with the vaccines containing HPV antigens.
Storage2°C to 8°C

Conclusions

In conclusion, the Human Papilloma-Specific IgG ELISA Kit is a state-of-the-art tool that provides invaluable insight into an individual's or a population's immune status against HPV. By complementing traditional HPV DNA testing, this serological assay enhances our ability to monitor vaccination programs, conduct large-scale epidemiological studies, and better understand the complex dynamics of HPV infection and immunity. Its role in both clinical research and public health is undeniable, contributing significantly to our global efforts to prevent and control HPV-related diseases.

Frequently Asked Questions (FAQ)

Antibody FAQs

Still have questions?

Contact Us

I can't. Whether it is natural infection or vaccination with VLP vaccine, the antibodies produced are specific to VLP, and this kit cannot distinguish their sources.

This is quite common. The reasons include: ①The antibodies have not been produced in the early stage of infection; ② Individual immune response is weak and fails to produce detectable antibody levels; ③ The antibodies have decayed below the detection limit after a previous infection.

Absolutely not recommended. Each type must be tested separately. Mixing different types of VLPs can introduce competitive binding, leading to decreased sensitivity and unreliable results.

Inquiry Basket
loading Loading ......

Inquiry

Inquiry